CClinicalTrials.gg
CompletedNCT02853773SUGARTUpdated Oct 26, 2017

Effects of Consuming Artificial Sweeteners and Sugar on Cerebral and Physiological Responses

An interventional study of ingestion of a test meal with sweetener and ingestion of a test meal with sweetener in Normal Subjects, sponsored by University of Lausanne. Completed at 1 site in Switzerland. Open to male participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-26.

Sponsored by University of Lausanne · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Male
01

Study summary

This study aims at investigating the acute influence of artificially sweetened beverages consumption (as compared with sugar-sweetened beverages and water consumption) on brain responses to the viewing of food images, on physiological responses (gut-derived hormones and lipid metabolites) and on the food intake behavior.

Read the detailed description

This study is made on a randomized controlled crossover design including three conditions (water, sugar, artificial sweeteners). Measurements will be performed in fasting and fed conditions. The test-meal will comprise either an artificially or sugar-sweetened beverage or water (control). The spatio-temporal brain dynamics to the viewing of food pictures will be assessed by means of electroencephalography (EEG) recordings and electrical neuroimaging analyses. Venous blood and urine will be collected. Blood pressure, cardiac frequency and bio-impedance measurements will be performed. Food intake behavior will be assessed by means of questionnaires and a free-choice buffet. Each tested condition (water, sugar, artificial sweeteners) will be preceded by a run-in period during which the participants' diet will be controlled (2-day isoenergetic diet).

02

Conditions studied

  • Normal Subjects

Keywords

  • sweeteners
  • sugar
  • EEG
  • food viewing
  • food intake
03

In context

Lead sponsor

University of Lausanne is the lead sponsor of 54 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy
  • Caucasian
  • Right-handed
  • Weak to normal physical activity (\< 3hours per week)
  • Normal-weight (19\<BMI\<25 kg/m2)
  • Regular consumption of sugar-sweetened beverages (>33cl per week)

Exclusion criteria

Exclusion Criteria:

  • Consumption of artificially sweetened beverages exceeding 33cl per week
  • Diabetes
  • Cardiovascular, kidney, hepatic and/or psychological disorders
  • Blood pressure at rest > 140/90mmHg
  • Body weight \< 50kg
  • Hemoglobin \< 13.5g/dl
  • Ferritin \< 50microg/l
  • Drug consumption
  • Alcohol consumption (>10g/day)
  • Smoking
  • Any particular diet (e.g. vegetarianism), food allergy and/or intolerance
  • Body weight gain or loss of >3kg during the last 3 months
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
18 participants (actual)

Study arms

  • Experimental
    Artificial sweetener

    Effects of co-ingestion of artificially sweetened beverage on the response to a test meal

    Other: ingestion of a test meal with sweetener

  • Active comparator
    Sugar

    Effects of co-ingestion of sugar-sweetened beverage on the response to a test meal

    Other: ingestion of a test meal with sweetener

  • Active comparator
    Water

    Effects of co-ingestion of water on the response to a test meal

    Other: ingestion of a test meal with water

Interventions

  • Otheringestion of a test meal with sweetener

    participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with artificially sweetened drinks

  • Otheringestion of a test meal with sweetener

    participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with sugary drinks drinks

  • Otheringestion of a test meal with water

    participants will ingest a test meal containing 55% carbohydrate, 30% fat and 15% protein with waters

06

What researchers measure

Primary outcomes

  1. Spatio-temporal brain dynamics

    Spatio-temporal brain dynamics to the viewing of food will be assessed by means of electroencephalography recordings.

    Time frame: differences observed between 60 min before and 60 min after ingestion of a test meal

Secondary outcomes

  1. Changes in concentration of blood insulin

    Blood substrate concentration will be measured in fasting conditions and after ingestion of a test meal

    Time frame: -120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal

  2. Changes in concentration of blood triglyceride

    Blood substrate concentration will be measured in fasting conditions and after ingestion of a test meal

    Time frame: -120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal

  3. Changes in concentration of blood Fibroblast Growth Factor (FGF)-21

    Blood substrate concentration will be measured in fasting conditions and after ingestion of a test meal

    Time frame: -120 min before ingestion of a test meal, and 30, 60, 90, 150, and 210 min after ingestion of a test meal

  4. spontaneous food intake

    Food intake behavior will be assessed by monitoring spontaneous food intake when offered a free-choice buffet.

    Time frame: 240 min after ingestion of a test meal

07

Study locations

1 site
  • Department of Physiology
    Lausanne, Vaud 1005, Switzerland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02853773
Lead sponsor
University of Lausanne
Collaborators
University of Lausanne Hospitals
Responsible party
Luc Tappy, MD (Full professor, University of Lausanne) — Principal investigator
First posted
Aug 3, 2016
Start date
Feb 2016
Primary completion
Sep 29, 2017
Completion
Sep 29, 2017
Last update
Oct 26, 2017

Study contacts

Luc Tappy, Professor
principal investigator · Department of Physiology, University of Lausanne, Switzerland

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion